Ronald Van Toorn

Prof. Ronald Van Toorn

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2014 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
RTRonald Van Toorn
Ronald Van Toorn
HSHendrik Simon Schaaf
Hendrik Simon Schaaf
JLJacoba A. Bcomm Laubscher
Jacoba A. Bcomm Laubscher
SESabine L. Msc van Elsland
Sabine L. Msc van Elsland
PDPeter R. Donald
Peter R. Donald
JSJohan F. Schoeman
Johan F. Schoeman
Background: The World Health Organization recommends 12-month treatment (2RHZE/10RH) for children with tuberculous meningitis (TBM). Studies evaluating length of antituberculous treatment for TBM report similar completion and relapse rates comparing 6-month treatment with 12-month treatment. Methods: A prospective evaluation to determine whether short-course intensified treatment (6 RHZEth for HIV-infected and 9RHZEth for HIV-infected) is sufficient and safe in children with drug-susceptible TBM. Results: Of 184 children with TBM, median age 58 months and 90 (49%) male, 98 children (53%) presented at stage II TBM, 64 (35%) at stage III TBM and only 22 (12%) at stage I TBM. Ninety (49%) children were treated at home after the first month of therapy; all others received their full treatment in hospital. The HIV prevalence was 14% (22/155 children tested). Anti-TB drug-induced hepatotoxicity occurred in 5% (8 of 143 children tested), all tested negative for viral hepatitis; in all 8 cases, the original regimen was restarted without recurrence. After treatment completion, 147 (80%) children had a good outcome, 7 (3.8%) died. There was no difference in outcome between HIV-infected and HIV-uninfected children who completed treatment (P = 0.986) nor between TBM-hydrocephalic children who were medically treated or shunted (P = 0.166). Conclusion: Short intensified treatment is safe and effective in both HIV-infected and HIV-uninfected children with drug-susceptible TBM.

1 March 2014 in Seminars in Pediatric Neurology
Verified
Journal Article
Closed access
RTRonald Van Toorn
Ronald Van Toorn
RSRegan Hi Solomons
Regan Hi Solomons

1 May 2012 in The International Journal of Tuberculosis and Lung Disease
Verified
Journal Article
Closed access
RTRonald Van Toorn
Ronald Van Toorn
PSP. Springer
P. Springer
JLJ. A. Laubscher
J. A. Laubscher
JSJ. F. Schoeman
J. F. Schoeman
The stage of tuberculous meningitis (TBM) at presentation is strongly associated with prognosis. To compare different staging systems for TBM in predicting outcome. The associations of different staging systems with neurological outcome were assessed using clinical, diagnostic and outcome data of 554 TBM children admitted to Tygerberg Children's Hospital from January 1985 to April 2005. The refined Medical Research Council (MRC) scale after 1 week (84%, 95%CI 81-88) had the highest discriminatory power in predicting neurological morbidity. The Glasgow Coma Score (GCS) on admission, GCS after 1 week, the 'refined' MRC scale on admission and Tygerberg Children's Hospital (TCH) staging method all had excellent discriminatory powers in predicting outcome. Improvement of staging after 1 week occurred in children who did not have signs of raised intracranial pressure (P = 0.004) or brainstem dysfunction on admission (P = 0.030). The 'refined' MRC scale 1 week after diagnosis showed the best association with neurological outcome after 6 months of treatment. The excellent discriminatory power of the TCH scale and its simplicity of use make it the ideal scale for use in resource-poor settings.

1 November 2005 in European Journal of Paediatric Neurology
Verified
Journal Article
Closed access
RTRonald Van Toorn
Ronald Van Toorn
HRHelena Rabie
Helena Rabie
JWJames M. Warwick
James M. Warwick

1 December 2020 in Tuberculosis
Verified
Journal Article
Open access
DZDan Zaharie
Dan Zaharie
DFDaniel J. Franken
Daniel J. Franken
MKMartijn van der Kuip
Martijn van der Kuip
SESabine van Elsland
Sabine van Elsland
BBBernadette Simone De Bakker
Bernadette Simone De Bakker
AFA.M. Tutu van Furth
A.M. Tutu van Furth
Of all tuberculosis (TB) cases, 1% affects the central nervous system (CNS), with a mortality rate of up to 60%. Our aim is to fill the 'key gap' in TBM research by analyzing brain specimens in a unique historical cohort of 84 patients, focusing on granuloma formation. We describe three different types: non-necrotizing, necrotizing gummatous, and necrotizing abscess type granuloma. Our hypothesis is that these different types of granuloma are developmental stages of the same pathological process. All types were present in each patient and were mainly localized in the leptomeninges. Intra-parenchymal granulomas were less abundant than the leptomeningeal ones and mainly located close to the cerebrospinal fluid (subpial and subependymal). We found that most of the intraparenchymal granulomas are an extension of leptomeningeal lesions which is the opposite of the classical Rich focus theory. We present a 3D-model to facilitate further understanding of the topographic relation of granulomas with leptomeninges, brain parenchyma and blood vessels. We describe innate and adaptive immune responses during granuloma formation including the cytokine profiles. We emphasize the presence of leptomeningeal B-cell aggregates as tertiary lymphoid structures. Our study forms a basis for further research in neuroinflammation and infectious diseases of the CNS, especially TB.

31 July 2004 in European Journal of Paediatric Neurology
Verified
Journal Article
Closed access
RTRonald Van Toorn
Ronald Van Toorn
HWHenriete H Weyers
Henriete H Weyers
JSJohan F Schoeman
Johan F Schoeman